Five-year outcome of a stroke cohort in martinique, French West Indies: Etude réalisée en martinique et centrée sur l'incidence des accidents vasculaires cérebraux, part 2

Stroke

Volumn 41, Issue 4, 2010, Pages 594-599

  Chausson, Nicolas ^a   Olindo, Stéphane ^a   Cabre, Philippe ^a   Saint Vil, Martine ^a   Smadja, Didier ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

Blacks; Epidemiology; Outcomes; Stroke

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT;

AFRICAN CARIBBEAN; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BARTHEL INDEX; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; COHORT ANALYSIS; COMMUNITY; DAILY LIFE ACTIVITY; DEPRESSION; DIABETES MELLITUS; DYSPHASIA; FEMALE; FUNCTIONAL STATUS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MARTINIQUE; MINI MENTAL STATE EXAMINATION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; STROKE; SURVIVOR; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DEPRESSION; DISABILITY EVALUATION; FEMALE; FRANCE; HUMANS; HYPERTENSION; MALE; MARTINIQUE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; STROKE; SURVIVORS; TREATMENT OUTCOME;

EID: 77950283263     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.573402     Document Type: Article

References (38)

1. Smaja D, Cabre P, May F, Fanon JL, Rene-Corail P, Riocreux C, Char-pentier JC, Fournerie P, Saint-Vil M, Ketterle J. ERMANCIA Study Group. ERMANCIA: epidemiology of stroke in Martinique, French West Indies, part I: methodology, incidence, and 30-day case fatality rate. Stroke. 2001;32:2741-2747.
2. Wolfe CD, Giroud M, Kolominsky-Rabas P, Dundas R, Lemesle M, Heuschmann P, Rudd A. Variations in stroke incidence and survival in 3 areas of Europe. European Registries of Stroke (EROS) Collaboration. Stroke. 2000;31:2074-2079.
3. Merle S, Pierre-Louis K, Rosine J, Cardoso T, Inamo J, Deloumeaux J. Arterial-hypertension prevalence in the general population of Martinique [in French]. Rev Epidemiol Sante Publique. 2009;57:17-23.
4. Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, Paik MC, Hauser WA. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol. 1998;147:259-268.
5. Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, Gebel J, Mills D, Minneci L, Shukla R. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415-421.
6. Stewart JA, Dundas R, Howard RS, Rudd AG, Wolfe CD. Ethnic differences in incidence of stroke: prospective study with stroke register. BMJ. 1999;318:967-971.
7. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61-65.
8. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
9. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
10. European Stroke Initiative Executive Committee; EUSI Writing Committee, Olsen TS, Langhorne P, Diener HC, Hennerici M, Ferro J, Sivenius J, Wahlgren NG, Bath P. European Stroke Initiative recommendations for stroke management-update 2003. Cerebrovasc Dis. 2003;16: 311-337.
11. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart-Wynne EG. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke. 2000;31:2080-2086.
12. Ikebe T, Ozawa H, Lida M, Shimamoto T, Handa K, Komachi Y. Long-term prognosis after stroke: a community-based study in Japan. J Epidemiol. 2001;11:8-15.
13. Wolfe CD, Corbin DO, Smeeton NC, Gay GH, Rudd AG, Hennis AJ, Wilks RJ, Fraser HS. Poststroke survival for black-Caribbean populations in Barbados and South London. Stroke. 2006;37:1991-1996.
14. Jorgensen HS, Nakayama H, Raaschou HO, Vive-Larsen J, Stoier M, Olsen TS. Outcome and time course of recovery in stroke, part II: time course of recovery. The Copenhagen Stroke Study. Arch Phys Med Rehabil. 1995;76:406-412.
15. Paolucci S, Antonucci G, Grasso MG, Bragoni M, Coiro P, De Angelis D, Romana Fusco F, Morelli D, Venturiero V, Troisi E, Pratesi L. Functional outcome of ischemic and hemorrhagic stroke patients after inpatient rehabilitation: a matched comparison. Stroke. 2003;34:2861-2865.
16. Robinson RG, Price TR. Post-stroke depressive disorders: a follow-up study of 103 patients. Stroke. 1982;13:635-641.
17. Naess H, Nyland HI, Thomassen L, Aarseth J, Myhr KM. Mild depression in young adults with cerebral infarction at long-term follow-up: a population-based study. Eur J Neurol. 2005;12:194-198.
18. Paul SL, Dewey HM, Sturm JW, McDonell RA, Thrift AG. Prevalence of depression and use of antidepressant medication at 5-years poststroke in the North East Melbourne Stroke Incidence Study. Stroke. 2006;37: 2854-2855.
19. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke. 2005; 36:1330-1340.
20. Farner L, Wagle J, Flekkøy K, Wyller TB, Fure B, Stensrød B, Engedal K. Factor analysis of the Montgomery-Asberg Depression Rating Scale in an elderly stroke population. Int J Geriatr Psychiatry. 2009;24: 1209-1216.
21. Pasquier F, Henon H, Leys D. Risk factors and mechanisms of post-stroke dementia. Rev Neurol (Paris). 1999;155:749-753.
22. Gagnon M, Letenneur L, Dartigues JF, Commenges D, Orgogozo JM, Barberger-Gateau P, Alpérovitch A, Décamps A, Salamon R. Validity of the Mini-Mental State Examination as a screening instrument for cognitive impairment and dementia in French elderly community residents. Neuroepidemiology. 1990;9:143-150.
23. Pantoni L, Poggesi A, Basile AM, Pracucci G, Barkhof F, Chabriat H, Erkinjuntti T, Ferro JM, Hennerici M, O'Brien J, Schmidt R, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D. LADIS Study Group. Leukoaraiosis predicts hidden global functioning impairment in non-disabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. J Am Geriatr Soc. 2006;54:1095-1101.
24. Tang WK, Chan SS, Chiu HF, Ungvari GS, Wong KS, Kwok TC, Mok V, Wong KT, Richards PS, Ahuja AT. Frequency and determinants of poststroke dementia in Chinese. Stroke. 2004;35:930-935.
25. Smeeton NC, Corbin DO, Hennis AJ, Hambleton IR, Fraser HS, Wolfe CD, Heuschmann PU. Differences in risk factors between black Caribbean patients with stroke in Barbados and South London. Stroke. 2009;40:640-643.
26. Tatemichi TK, Paik M, Bagiella E, Desmond DW, Stern Y, Sano M, Hauser WA, Mayeux R. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology. 1994;44:1885-1891.
27. Henon H, Durieu I, Lebert F, Pasquier F, Leys D. Influence of prestroke dementia on early and delayed mortality in stroke patients. J Neurol. 2003;250:10-16.
28. Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, Chalmers J. PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163:1069-1075.
29. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, Bossini A, Fagard R, Gil-Extremera B, Laks T, Kobalava Z, Sarti C, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Birkenhäger WH. Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002; 162:2046-2052.
30. Verberk WJ, Kroon AA, Kessels AG, de Leeuw PW. Home blood pressure measurement: a systematic review. J Am Coll Cardiol. 2005;46: 743-751.
31. Ohta Y, Tsuchihashi T, Ibayashi S, Matsumura K, Kitazono T, Ooboshi H, Kamouchi M, Fujii K, Iida M. Blood pressure control in hypertensive patients with a history of stroke. J Stroke Cerebrovasc Dis. 2005;14: 229-233.
32. Amar J, Cambou JP, Touze E, Bongard V, Jullien G, Vahanian A, Coppe G, Mas JL. On behalf of the ECLAT1 Study investigators. Comparison of hypertension management after stroke and myocardial infarction: results from ECLAT1, a French nationwide study. Stroke. 2004;35:1579-1583.
33. Paul SL, Thrift AG. Control of hypertension 5 years after stroke in the North East Melbourne stroke incidence study. Hypertension. 2006;48: 260-265.
34. Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S, MacMahon S, Neal B. PROGRESS Collaborative Group. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens. 2006;24:1201-1218.
35. Xu G, Liu X, Wu W, Zhang R, Yin Q. Recurrence after ischemic stroke in Chinese patients: impact of uncontrolled modifiable risk factors. Cerebrovasc Dis. 2007;23:117-120.
36. Escobar C, Barrios V. Diabetes and hypertension: which is the best approach? Expert Rev Cardiovasc Ther. 2009;7:269-271.
37. Brewster LM, van Montfrans GA, Kleijnen J. Systematic review: anti-hypertensive drug therapy in black patients. Ann Intern Med. 2004;141: 614-627.
38. Cushman WC, Basile J. Achieving blood pressure goals: why aren't we? J Clin Hypertens. 2006;8:865-872.